- The Wall Street Journal•2 days ago
Quintiles IMS Holdings Inc. aims to provide its clinical-trial and prescription-drug data through the cloud-based technology developed by Salesforce.com.
- Business Wire•2 days ago
QuintilesIMS Announces Alliance with Salesforce to Build Next Generation Solutions for Life Sciences Firms — From Molecule to Market
QuintilesIMS , a leading provider of information, technology services and contract research to the life sciences industry, today announced an alliance with Salesforce, the world’s #1 CRM company and Intelligent Customer Success Platform, to offer life sciences companies new capabilities to move treatments more efficiently and effectively, from molecule to market.
- Business Wire•7 days ago
Quintiles IMS Holdings, Inc. will announce its first-quarter 2017 financial results before the market opens on Wednesday, May 3, 2017. The QuintilesIMS management team will host a conference call and webcast at 9:00 a.m.
Q : Summary for Quintiles IMS Holdings, Inc. Co - Yahoo Finance
Quintiles IMS Holdings, Inc. (Q)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||82.37 - 83.49|
|52 Week Range||61.21 - 83.97|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||109.24|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|